In this case report, we discuss the clinical course, therapeutic decisions, and implications for managing a patient with inherited thrombophilia characterized by protein S deficiency (type I) and heterozygous Factor V Leiden mutation who is diagnosed with CML. The gene discussed is F5; the disease is hyperinsulinemic hypoglycemia, familial, 4.